Post-translational modification of SOX family proteins: Key biochemical targets in cancer?
Open Access
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 67, 30-38
Abstract
No abstract availableKeywords
Funding Information
- Brain Tumour Charity Quest
- BBSRC
- EPSRC
- MRC (MR/N024028/1)
- Cancer Research UK (C65925/A26986)
This publication has 100 references indexed in Scilit:
- Transcription factors: from enhancer binding to developmental controlNature Reviews Genetics, 2012
- Systematic and Quantitative Assessment of the Ubiquitin-Modified ProteomeMolecular Cell, 2011
- Novel functions for the anaphase-promoting complex in neurobiologySeminars in Cell & Developmental Biology, 2011
- The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA templateNucleic Acids Research, 2010
- The SoxD transcription factors – Sox5, Sox6, and Sox13 – are key cell fate modulatorsThe International Journal of Biochemistry & Cell Biology, 2010
- Rho kinase–dependent activation of SOX9 in chondrocytesArthritis & Rheumatism, 2009
- Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in MelanomaMolecular Cell, 2009
- Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5Nucleic Acids Research, 2008
- A proteomics approach to understanding protein ubiquitinationNature Biotechnology, 2003
- A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motifNature, 1990